Qilu Hospital of Shandong University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Effect of Probiotics on Gut Microbiota During the Helicobacter Pylori Eradication
Not Applicable
Not yet recruiting
- Conditions
- Gut MicrobiotaHelicobacter Pylori Infection
- Interventions
- Dietary Supplement: Bifidobacterium animalis subsp. lactis BLa80Other: Placebo
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 100
- Registration Number
- NCT05662514
The Clinical Features and Pregnancy Outcomes of RA Patients
Recruiting
- Conditions
- Pregnancy RelatedRheumatoid Arthritis
- Interventions
- First Posted Date
- 2022-12-15
- Last Posted Date
- 2022-12-15
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 100
- Registration Number
- NCT05651373
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Recruiting
- Conditions
- Antiphospholipid Syndrome
- Interventions
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 80
- Registration Number
- NCT05644210
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
Recruiting
- Conditions
- Hypertension
- Interventions
- Other: Left ventricular hypertrophyOther: Left ventricular non-hypertrophy
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 2200
- Registration Number
- NCT05638503
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
A Study of Fractional Carbon Dioxide Laser Treatment for Female Stress Urinary Incontinence
Not Applicable
Recruiting
- Conditions
- Stress Urinary Incontinence
- Interventions
- Procedure: Fractional carbon dioxide laser sham treatmentProcedure: Fractional carbon dioxide laser treatment
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 120
- Registration Number
- NCT05629481
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
The Clinical Efficacy of Immunomodulators in RA Patients
Phase 4
Recruiting
- Conditions
- Arthritis, Rheumatoid
- Interventions
- First Posted Date
- 2022-11-23
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 400
- Registration Number
- NCT05626348
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
Lianhua Qingwen for the Rehabilitation of Patient With Coronavirus Infection
Phase 4
Recruiting
- Conditions
- Traditional Chinese MedicineCoronavirus
- Interventions
- Drug: Lianhua Qingwen capsules
- First Posted Date
- 2022-11-22
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 4000
- Registration Number
- NCT05625035
- Locations
- 🇨🇳
International Convention and Exhibition Center Shelter Hospital, Urumqi, Xinjiang, China
Lianhua Qingke for the Rehabilitation of Patient With Omicron Infection
Phase 4
Recruiting
- Conditions
- CoronavirusTraditional Chinese Medicine
- Interventions
- First Posted Date
- 2022-11-22
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 2000
- Registration Number
- NCT05625022
- Locations
- 🇨🇳
International Convention and Exhibition Center Shelter Hospital, Urumqi, Xinjiang, China
Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma
Completed
- Conditions
- Carcinoma
- Interventions
- Other: no intervention
- First Posted Date
- 2022-10-25
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 100
- Registration Number
- NCT05593744
- Locations
- 🇨🇳
Qilu Hospital, Shandong University, Jinan, Shandong, China
Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy
Phase 2
Recruiting
- Conditions
- Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Interventions
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 59
- Registration Number
- NCT05585580
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
🇨🇳Qingdao Municipal Hospital（Group）, Qingdao, Shandong, China
🇨🇳Yantai Yuhuangding Hospital, Yantai, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath